| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |